Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial. Ann Intern Med. 2011 05 03; 154(9):573-82.